Avalo Therapeutics Inc (AVTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $448.71M
Last updated: Nov 17, 2026 at 11:04 AM ET
Avalo Therapeutics Inc (AVTX) Competitors
The companies most similar to Avalo Therapeutics are Indaptus Therapeutics (INDP), Alector (ALEC) and Kyverna Therapeutics, Inc. Common Stock (KYTX). By market cap, Avalo Therapeutics ranks 5th of the 13 companies on this page; OmniAb (OABI) is the largest at $716.17M.
Peer Comparison
AVTX's revenue growth of -69.3% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics (AVTX) | $448.71M | N/A | N/A | 0.0% | N/A | -69.3% | 0.00% |
| Indaptus Therapeutics Inc (INDP) | $422.38M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Alector Inc (ALEC) | $378.15M | 7.3x | 1.7x | 23.9% | N/A | 4896.0% | 0.00% |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | $319.27M | N/A | N/A | 0.0% | -81.5% | 0.0% | 0.00% |
| Zevra Therapeutics Inc. (ZVRA) | $540.30M | 11.6x | 3.7x | 52.8% | N/A | 44.9% | 0.00% |
| Candel Therapeutics Inc (CADL) | $486.37M | N/A | N/A | 0.0% | -43.5% | 0.0% | 0.00% |
| Larimar Therapeutics Inc (LRMR) | $313.73M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| OmniAb Inc. (OABI) | $716.17M | N/A | 15.7x | -108.1% | -17.5% | 78.3% | 0.00% |
| Gyre Therapeutics Inc. (GYRE) | $471.74M | N/A | 3.8x | -22.7% | N/A | 0.7% | 0.00% |
| Prelude Therapeutics Inc (PRLD) | $275.32M | N/A | 16.3x | -269.7% | N/A | 41.0% | 0.00% |
| Prothena Corporation plc (PRTA) | $419.01M | N/A | 7.8x | -45.4% | N/A | -74.3% | 0.00% |
| Rezolute Inc (RZLT) | $353.54M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Fulcrum Therapeutics Inc (FULC) | $287.96M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $398.58M | 9.5x | 5.8x | 0.0% | -43.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Avalo Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Indaptus Therapeutics Inc (INDP) | Indaptus Therapeutics Inc. is a pioneering biotechnology firm focused on advancing immunotherapies that aim to transform cancer treatment paradigms. | INDP competitors |
| Alector Inc (ALEC) | Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases. | ALEC competitors |
| Kyverna Therapeutics, Inc. Common Stock (KYTX) | Kyverna Therapeutics, Inc. is an innovative biotechnology company focused on advancing immunotherapies for autoimmune diseases and other significant health... | KYTX competitors |
| Zevra Therapeutics Inc. (ZVRA) | Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions... | ZVRA competitors |
| Candel Therapeutics Inc (CADL) | Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform... | CADL competitors |
| Larimar Therapeutics Inc (LRMR) | Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. | LRMR competitors |
| OmniAb Inc. (OABI) | OmniAb Inc. is an innovative biotechnology company dedicated to the development of fully human therapeutic antibodies via its advanced OmniAb platform. | OABI competitors |
| Gyre Therapeutics Inc. (GYRE) | Gyre Therapeutics Inc. is a pioneering biopharmaceutical company at the forefront of developing advanced therapies for rare and complex diseases. | GYRE competitors |
| Prelude Therapeutics Inc (PRLD) | Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized... | PRLD competitors |
| Prothena Corporation plc (PRTA) | Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases... | PRTA competitors |
| Rezolute Inc (RZLT) | Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. | RZLT competitors |
| Fulcrum Therapeutics Inc (FULC) | Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined... | FULC competitors |
Frequently Asked Questions About AVTX
Who are Avalo Therapeutics' main competitors?
The companies most similar to Avalo Therapeutics include Indaptus Therapeutics (INDP), Alector (ALEC), Kyverna Therapeutics, Inc. Common Stock (KYTX), Zevra Therapeutics (ZVRA) and Candel Therapeutics (CADL), listed from the closest match.
Who is Avalo Therapeutics' biggest competitor?
OmniAb (OABI) is the largest of the similar companies at $716.17M; Indaptus Therapeutics (INDP) is the closest match by business profile, size, sector and industry.
How does AVTX stock compare with its competitors?
AVTX's net margin is 0.0% against a peer median of 0.0%.
Which of Avalo Therapeutics' competitors pays a higher dividend?
Avalo Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Avalo Therapeutics bigger than its competitors?
No. Avalo Therapeutics is 5th by market cap among the 13 companies on this page; the largest is OmniAb (OABI) at $716.17M.
AVTX pages: Overview, Earnings, Forecast, Financials, Competitors